EUCTR2006-001200-36-SE进行中（未招募）不适用
A prospective, randomized, masked and controlled trial of intravitreal bevacizumab (Avastin) versus verteporfin photodynamic therapy (PDT) in patients with neovascular age-related macular degeneration.
St. Eriks Eye Hospital0 个研究点目标入组 100 人开始时间: 2006年6月22日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with neovascular AMD aged 50 years or more who have a visual acuity
- •0,1 (20/200) or better
- •- Classic or predominantly classic choroidal neovascularization (CNV)
- •- Occult CNV with extension 4 disc areas or less
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients < 50 years of age
- •- Minimally classic CNV (predominantly occult CNV)
- •- Occult CNV with lesions > 4 disc areas
- •- Subretinal hemorrhage involving macular area and which is >= 1 disc area
- •or >=50% of the total lesion
- •- Subretinal fibrosis in the fovea
- •- Previous treatment using vitreoretinal surgery, PDT, transpupillary thermotherapy (TTT), argon or krypton laser, anecortave acetate or anti-VEGF agents for ocular use.
- •- Retinal vascular disease of any origin, leading to neovascularization
- •- Diabetic retinopathy
- •- Uncontrolled arterial hypertension
- •- Coronary infarction within the last 12 months
- •- Stroke within the last 12 months
研究者
相似试验
进行中（未招募）
不适用
A prospective, randomized, masked and controlled trial of intravitreal bevacizumab (Avastin®) for central retinal vein occlusion (CRVO).Central retinal vein occlusion (CRVO) is a sight-threatening ocular condition without efficient treatment.EUCTR2008-006265-93-SESt Eriks Eye Hospital60
进行中（未招募）
不适用
A prospective, randomized, masked and controlled trial of intravitreal ranibizumab (Lucentis®) combined with transpupillary thermotherapy (TTT) in patients with neovascular age-related macular degeneration (AMD)Age-related macular degeneration (AMD) is the leading cause of visual impairment and social blindness in people 60 years or older. Approximately 80% of patients with severe visual loss exhibit neovascular AMD with choroidal neovascularization (CNV). Newly formed vessels invade the retinal pigment epithelium (RPE) and neural retina, causing edema and hemorrhage, ultimately inducing damage or apoptotic cell death of photoreceptors.EUCTR2007-005462-12-SESt. Eriks Eye Hospital100
招募中
不适用
A prospective clinical trial for the treatment of keratoconjunctivitis caused by microsporidia.CTRI/2011/11/002132Hyderabad Eye Research Foundation72
进行中（未招募）
不适用
A prospective, controlled, randomized, patient and evaluator blinded study to evaluate pain and further disabling complications in patients undergoing Lichtenstein technique for primary inguinal hernia repair by fixing the mesh with TISSUCOL/TISSEEL fibrin sealant versus sutures. - TIMELI 001nilateral, uncomplicated primary inguinal hernia repairClassification code 10022020EUCTR2005-002741-39-DKniversità di Milano, Dipartimento di Scienze Chirurgiche, Ospedale Maggiore Policlinico, Padiglione328
进行中（未招募）
1 期
A prospective, controlled, randomized, patient and evaluator blinded study to evaluate pain and further disabling complications in patients undergoing Lichtenstein technique for primary inguinal hernia repair by fixing the mesh with TISSUCOL/TISSEEL fibrin sealant versus sutures.EUCTR2005-002741-39-ESPr Giampiero CAMPANELLI - Ospedale Maggiore Policlinico, Padiglione Beretta Est328